Featured in the journal Science and unveiled at last year’s International Society for Advancement of Cytometry CYTO conference, BD‘s first-of-its-kind cell-sorting technology has now launched ...

BD (NYSE:BDX) announced yesterday that it launched the HemoSphere Stream module for blood pressure monitoring.

Flow cytometry is a powerful, emerging technology that can help medical professionals better understand disease, according to Dr. Bill Hanlon, chief scientific officer of Labcorp Drug Development.

FRANKLIN LAKES, N.J., July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination ...

FRANKLIN LAKES, N.J., Dec. 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of new ...

BD Prevue™ II System Equips Clinicians with Connected Ultrasound Technology to Drive More Intuitive IV Placement and Control FRANKLIN LAKES, N.J., April 11, 2023 /PRNewswire/ -- BD (Becton, Dickinson ...

The Parata Systems team will work with BD’s medication management solutions business, according to a July 18 news release. The company plans to focus on issues including clinician shortages, wage ...

BD demonstrated how its portfolio supports the evolving needs of pharmaceutical and biotechnology companies developing biologics – GLP-1 therapies, vaccines, and acute care medicines – as the industry ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced the successful completion of a joint feasibility study evaluating the recycling of polystyrene Petri dishes into ...